Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · IEX Real-Time Price · USD
4.160
+0.050 (1.22%)
At close: Jul 19, 2024, 4:00 PM
4.220
+0.060 (1.44%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $6.41 million as of July 22, 2024. Its market cap has increased by 28.18% in one year.
Market Cap
6.41M
Enterprise Value
-1.41M
1-Year Change
28.18%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $6.41M, a decrease of -86.56%. That is a compound annual growth rate of -22.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 6.40M | 20.75% |
Dec 29, 2023 | 5.30M | 23.26% |
Dec 30, 2022 | 4.30M | -75.14% |
Dec 31, 2021 | 17.30M | 35.16% |
Dec 31, 2020 | 12.80M | 54.22% |
Dec 31, 2019 | 8.30M | -46.10% |
Dec 31, 2018 | 15.40M | -7.78% |
Dec 29, 2017 | 16.70M | -53.09% |
Dec 30, 2016 | 35.60M | -25.37% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sunshine Biopharma | 6.88M |
Alaunos Therapeutics | 6.76M |
Tenax Therapeutics | 6.70M |
NuCana | 6.69M |
Telesis Bio | 6.69M |
Chromocell Therapeutics | 6.40M |
ReShape Lifesciences | 6.21M |
Pasithea Therapeutics | 6.10M |